Are weight loss injections safe for seniors and older adults?

GLP-1 medicines such as tirzepatide (Mounjaro) and semaglutide (Wegovy) have no upper age limit in their UK licences, but a prescriber weighs all existing conditions and medicines before prescribing.
Muscle mass loss is a genuine consideration in older adults; adequate protein intake and strength-based activity alongside treatment are important — your prescriber can discuss this.
Dehydration from GI side effects can affect older adults more acutely; staying well hydrated and knowing when to seek help matters.
Report any suspected side effects through the MHRA's Yellow Card scheme, older adults on multiple medicines are encouraged to use it.

For older adults considering GLP-1 medicines such as Mounjaro or Wegovy, the honest answer is: these are prescription-only treatments that can be appropriate for people in their 60s, 70s and beyond, but age brings additional factors a prescriber must weigh carefully. Safety depends far more on an individual's health picture than on a birth year alone. Both tirzepatide and semaglutide are licensed for adults without an upper age cut-off, and NHS guidance on tirzepatide covers general use in adults; what changes for older patients is the context around that use. These are prescription-only medicines — a prescriber assesses whether they are suitable for you specifically before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What older adults and their families need to weigh up before starting

Age alone isn't the deciding factor, your health picture is

There is no licensed upper age limit for tirzepatide or semaglutide in the UK. A 72-year-old with well-managed hypertension and a BMI above 30 could, in principle, be a suitable candidate; a 65-year-old with uncontrolled kidney disease or a history of pancreatitis might not be. The prescriber's job is to read the whole picture.

What actually shifts with age is the surrounding medical context. Older adults are more likely to be taking multiple medicines. GLP-1 treatments slow gastric emptying, which can alter the absorption timing of other oral drugs. If you take medicines where timing matters precisely (certain blood-pressure tablets, thyroid replacements, anticoagulants) that interaction needs careful review. Our clinical team looks at this as part of every consultation.

Kidney function also deserves attention. Severe dehydration from GI side effects (nausea, vomiting, diarrhoea) can tip into acute kidney injury more readily in older adults. This isn't a reason to rule treatment out; it's a reason to titrate slowly, take the starter dose seriously, and have a clear plan for managing any early GI effects. The broader safety profile of weight loss injections is well-documented, and the clinical trials included adults well into their 60s.

The muscle-loss question, and why it matters more past 60

One of the most legitimate concerns raised by clinicians treating older adults on GLP-1 medicines is sarcopenia: the gradual loss of skeletal muscle that accelerates with age. Significant weight loss, from any cause, can reduce both fat and lean mass. For a 35-year-old, that ratio is easier to address. For someone in their late 60s who already has lower baseline muscle mass, it warrants a more deliberate approach.

The practical answer isn't to avoid treatment; it's to treat alongside a strategy that supports muscle. That means adequate protein at every meal (many people find appetite suppression makes this harder, not easier, something worth flagging to your prescriber), resistance exercise where mobility allows, and regular check-ins. A weight loss injection in this setting works best as one component of a broader plan, not a standalone fix.

Falls risk is related to this. Rapid weight loss can sometimes affect balance and postural stability in older adults, particularly in the early months. This is worth discussing openly before you start, not discovering halfway through a dose increase.

The NHS England guidance on weight management injections notes the importance of wraparound care (diet and activity support) precisely because the medicine alone isn't the full picture for anyone, but especially for older patients.

When to get medical help: side effects that need prompt attention

Most GI side effects (nausea, loose stools, indigestion, reduced appetite) are at their worst in the first few weeks of a new dose and settle for most people. But older adults should know which symptoms require a call to 111 or a GP rather than watchful waiting.

Seek help the same day if you experience severe, persistent stomach pain that radiates to the back, with or without vomiting. This can be a sign of pancreatitis, the MHRA issued a specific Drug Safety Update on this risk for GLP-1 medicines in January 2026. It is uncommon, but it is serious.

Also get medical attention for: signs of significant dehydration (dizziness on standing, dark urine, very little urine output) after a bout of vomiting or diarrhoea; any allergic reaction (swelling of the face, throat, lips or tongue, difficulty breathing); or a sudden change in mood, low mood or thoughts of self-harm.

Injection-site reactions are common and usually mild. Rotating sites (abdomen, thigh, upper arm) keeps them manageable. If a site becomes significantly swollen, hard or painful, mention it to your prescriber. Practical questions about administration, including needle changes, come up often; the FAQs cover some of these, and our team is available seven days a week.

You can report any suspected side effect (including one you're not sure about) through the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk. Older adults on several medicines are particularly encouraged to report, because that data helps regulators spot interactions that clinical trials can miss.

How the consultation works if you're older and already on other treatments

The consultation process at nume isn't a tick-box form. A GPhC-registered Independent Prescriber reads your answers personally, your existing conditions, your current medicines list, your weight history. For older adults, this review matters even more than it does for a 45-year-old with no comorbidities, and that's exactly why the process is structured the way it is.

If treatment is clinically suitable, the pen arrives in a plain DPD-tracked box to your door the next working day, no trip to a chemist, no waiting room. But the more important point is what happens before it arrives: a real clinical review of whether it should be prescribed at all, including whether the new weight loss injections are safe for your specific circumstances.

You can read more about how the service works on the about us page, or explore the full range of available treatments on the weight loss page. If cost is a consideration, what these treatments typically cost is covered separately. Our prescribers discuss suitability, your specific medicines list, and any age-related considerations as part of every consultation, there's no extra step to request it, and if you're wondering whether weight loss injections are safe for someone in your situation, or even whether weight loss injections give you energy alongside the other effects, those are exactly the kinds of questions worth raising. Start your free consultation if you'd like to talk it through.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions